P2RX5, purinergic receptor P2X 5, 5026

N. diseases: 132; N. variants: 6
Disease: Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.020 Biomarker group BEFREE Purinergic receptor-based signaling holds the therapeutic potential based on its role in cell proliferation of several carcinomas. 31401785 2019
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.020 Biomarker group BEFREE LRH-1 immunohistochemistry of 329 invasive carcinomas and ductal carcinoma <i>in situ</i> (DCIS) was performed. 29137369 2017